Browsing Category
Medicine
Pfizer: Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that following a request from the U.S. Food and Drug Administration (FDA) the companies have initiated a rolling submission seeking to amend the Emergency Use!-->…
Heart travels 350 kilometres to save a Kashmiri woman in MGM Healthcare, Chennai
Mumbai: Doctors at the MGM Healthcare Hospital gave a new lease of life to a 33-year-old underprivileged woman from Kashmir by successfully performing a heart transplant surgery.
A 33-year-old female hailing from Kashmir who…
Pfizer: European Commission Approves LORVIQUA® (lorlatinib) as a First-Line Treatment for…
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) granted marketing authorization for LORVIQUA® (lorlatinib, available in the U.S. under the brand name LORBRENA®) as monotherapy for the treatment of adult patients!-->…
Pfizer: Pfizer and Ionis Announce Discontinuation of Vupanorsen Clinical Development Program
Pfizer Inc. (NYSE: PFE) and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced the discontinuation of the Pfizer-led clinical development program for vupanorsen (PF-07285557), an investigational antisense therapy that was being!-->…
CARDIOLOGY DEPARTMENT, IMS, BHU, SUCCESSFULLY CONDUCTS RARE HEART PROCEDURE
VARANASI : A healthy heart paves way for a healthy and healthy life. Doctors at Department of Cardiology of Institute of Medical Sciences, Banaras Hindu University, are putting in their best efforts to realize this statement as and when an…
Pfizer: Pfizer and BioNTech Publish Data from Two Laboratory Studies on COVID-19 Vaccine-induced…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the publication of new results from two laboratory studies demonstrating that three doses of the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) elicited antibodies that!-->…
Pfizer: Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for…
Pfizer Inc. (NYSE: PFE) and OPKO Health, Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for somatrogon. Somatrogon is!-->…
Pfizer: Pfizer Shares In Vitro Efficacy of Novel COVID-19 Oral Treatment Against Omicron Variant
Pfizer Inc. (NYSE: PFE) today shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets), is!-->…
Pfizer: Pfizer to Provide U.S. Government with an Additional 10 Million Treatment Courses of its…
Pfizer Inc. (NYSE: PFE) announced that the U.S. government has committed to purchasing an additional 10 million treatment courses of its COVID-19 oral therapy, PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets). This commitment will!-->…
Pfizer: Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles (herpes zoster virus, or!-->…